Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Trial Evaluating Modified FOLFIRINOX and FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma

NCT07844057 is registered in ClinicalTrials.gov with Annika Kurreck as lead sponsor.

NCT NCT07844057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07844057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Trial Evaluating Modified FOLFIRINOX and FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma
Lead sponsor
Annika Kurreck
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
April 1, 2034
Enrollment
86 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, metastatic disease, small-bowel adenocarcinoma